icon-account icon-glass


Prozac withdrawal length success video

Prozac has the longest half-life of any antidepressant, or the length of time it takes to leave the body. Prozac targets Serotonin, the neurotransmitter found primarily in the gastrointestinal tract, blood platelets and throughout the central nervous system.  This explains why the side effect profile of Prozac can affect so many systems of the body.  Weaning off Prozac must be done slowly to provide ample opportunity for the readjustment of the Serotonin receptors. [1 Due to the long half life, many do not realize the extent of the Prozac withdrawal length / duration and that they are in serious withdrawal for weeks after stopping Prozac, then the nightmares, insomnia, anxiety, reoccurrence of depression and other common Prozac Withdrawal symptoms emerge.   Prozac is often used as a bridge to prevent SSRI withdrawals, but many do not respond well to Prozac or have serotonin levels increase out of safe ranges from combining Prozac with their other antidepressant. Our nonprofit has spent over 17 years helping people taper Prozac and all antidepressants properly.  We focus on healing during the tapering process and are careful to ensure no interactions items are used that could put you at risk.  Contact our nonprofit for help to taper off Prozac.*

Kelly weaning off prozac success

I am FREE and I got my TESTIMONY back!

by Kelly (USA)

I am in a much better condition to take control of my life and make decisions based on clarity, rather that emotional turmoil.

by Marilyn (USA)
Marilyn’s prozac withdrawal length success story


Prozac was the first antidepressant released on the market and Prozac is the brand name for Fluoxetine.  Prozac can cause both psychological and physical dependency since it both alters mood and also acts on Serotonin receptors located throughout the body.  Physiological dependence occurs when the body has adapted to the drug and requires regular doses to function normally. Psychological dependence is due to the increased levels of Serotonin, a neurochemical responsible for feelings of well-being. [2]  Missing a dose or reducing too rapidly can produce both mental and physical symptoms that can interrupt all aspects of life. This is why our nonprofit implements a plan of slowly weaning off Prozac combined with a powerful holistic approach to easing symptoms, providing a much smoother withdrawal process.* 


Prozac has a much longer half-life, or the time it takes to leave the body, than other antidepressants making the Prozac withdrawal length or duration longer than other antidepressants. For many this long action provides a more comfortable withdrawal process.  While severe withdrawal symptoms are less common with Prozac than other antidepressant, the withdrawal symptoms typically last longer since Prozac does not fully leave the body for an average of 30 days. [3] The common Prozac withdrawal symptoms include irritability, nightmares, gastrointestinal disturbances and anxiety.  Gradually lowering the dose is critical to control Prozac withdrawal symptoms, yet many find they also need relief due to the alteration of the Serotonin receptors.  We utilize a proven holistic approach used for over 17 years to ease withdrawal symptoms and augment healing of the receptors.  If you need help weaning off Prozac, contact our nonprofit.*

The debt of gratitude I owe you is something I can never repay. My family and I will be forever grateful.

by Rachel - Antidepressant Withdrawal Success


Over the last 17 years Point of Return has helped people all over the world to escape dependence to addictive medications. Although Prozac is a long-acting antidepressant, meaning the Prozac withdrawal length or duration is longer than other antidepressants, weaning off Prozac slowly is recommended to control Prozac Withdrawals commonly called the Prozac Discontinuation Syndrome. [4]  The Point of Return Program is a proven, holistic approach that allows you to wean off Prozac while helping to ease symptoms and promoting sleep with supplements that will not interact, yet provide the necessary relief.  Your Prozac at-home weaning program is done under the guidance of Our Team, Your Physician and Pharmacist, and allows you to wean off Prozac at rates not available by the pharmaceutical companies.  Our pre-taper is for Prozac symptom relief - you will not taper Prozac until you feel better. This is where our advanced nutraceuticals and holistic approach are critical due to the unique demands placed on your body and nervous system by the Prozac. Point of Return provides healthy, proven, Drug-Free strategies to help ease Prozac Withdrawal symptoms while supporting your well being.* 

Our areas of expertise are Antidepressants, Benzodiazepines, Sleeping Pills and Painkillers on a case-by-case basis.  Our innovative approach to antidepressant tapering encompasses a holistic method to empower you on your path to recovery. No need to attempt Prozac Withdrawal on your own, work with us.*

Weaning off Prozac properly with Point of Return


  • shaking
  • confusion
  • dizziness
  • sweating
  • severe headache 
  • insomnia
  • anxiety 
  • burning or tingling sensations around the body
  • brain zaps / brain shivers
  • vertigo
  • lightheadedness
  • rushing noise in the head
  • agitation
  • negative
  • tearful
  • concentration problem
  • tremors
  • diarrhea
  • vomiting
  • reduced appetite
  • nightmares
  • excessive dreaming
  • gastrointestinal issues  [4]

The debt of gratitude I owe you is something I can never repay. My family and I will be forever grateful.

by Tom Antidepressant Withdrawal Success


 Proven Program completed At-Home

✔ Slowly Stop Taking Prozac

✔ All-Natural Nutraceuticals to help ease symptoms and make Prozac Withdrawal more comfortable*

✔ Professional information on interactions 

✔ Free Mentoring on our 24/7 private Discussion Board


Enter Discount Code ADFree for FREE Ground Shipping on your Withdrawal Program (USA & Canada Only)

Help Weaning off Prozac


The half-life of Prozac, or the time to clear the body, is the longest for any antidepressant, approximately 4-6 days for the active metabolite and 30 days to fully leave the body. [5]  However, this does not mean that all withdrawal symptoms start after a month. Many feel even a small reduction in Prozac since it is estimated that 56% of people experience withdrawal effects with 46% reporting severe symptoms. One study found that 67% of people taking Prozac experienced withdrawal symptoms including a feeling of detachment, electric shock in the head (brain zaps), anxiety, depression, gastrointestinal disturbances, flu-like symptoms, and many others.  Please, do not attempt to stop Prozac on your own.  Contact our Prescription Drug Experts who have assisted people in 87 countries to regain their lives.  Contact us today!*

Eric - Prozac Withdrawal Length Help and Success

For those currently struggling, try the program.  Give the POR team a call or email.   Also, find faith to help you through.  If you are a Christian, cling to Jesus!

By Eric Prozac Withdrawal Success

Is it Your Time to Start a New Journey?


Betty - Prozac Withdrawal Length Help

 I Thank you Point of Return for all of your patience and kindness.  We in a fragile state need your extra kindness.  Thank you for all you have done for me and my roach to recovery. More...

Betty (Prozac Withdrawal Success Story)

Eric - Help weaning off Prozac

 I also need to thank the whole Point of Return staff.  I called many times looking for help and always got an uplifting word or laugh. For those currently struggling, try their withdrawal  program. Give the Point of Return team a call or email. More...

Eric (Prozac Withdrawal Success Story)

Rachel - Prozac Withdrawal Length Help

  I have found that if you work the Point of Return program that it will work for you.  The results are there if you do your part and work the program. I strongly recommend Point of Return to others. More...

Rachel (Prozac Withdrawal Success Story)



Message sent, thanks! Will get back to your shortly.


using a Natural Approach

Success overcoming Prozac withdrawal length with our team

Our team has survived psychoactive drug withdrawal. More...

Weaning off Prozac - anywhere in the world

We've helped people in 78 countries and in every state of the USA. More...

Media about Weaning off Prozac

We have extensive media coverage; television, print, radio. More...   








    Prozac targets Serotonin, the neurotransmitter found primarily in the gastrointestinal tract, blood platelets and central nervous system, and is thought to contribute to feelings of happiness. 

    Prozac has the longest half-life of any antidepressant, meaning it stays in the body for an extended period of time. Many patients do not realize they are in withdrawal as the symptoms may appear weeks after stopping the drug. A gradual taper is recommended yet many still find the symptoms too challenging and need assistance. 

    Prozac (Fluoxetine) failed in clinical trials as an antihypertensive medication and again as an obesity drug. While it did not show improvement for patients hospitalized as psychotic and actually made some patients worse, Prozac found its home as an antidepressant after it improved the mood of five mildly depressed volunteers. It was then launched as an antidepressant in 1988 and was responsible for more than one-quarter of Eli Lilly Pharmaceutical's income. The marketing strategy of providing a cure for an illness was born by Interbrand, the world's leading branding company (Microsoft, Nikon, Nintendo, Sony) and the name Prozac was chosen because it was short and had a positive and professional sound. Lilly printed 8 million brochures highlighting the symptoms of depression with a treatment option and patients began asking for the drug by name. It was the success of Prozac that created the market with similar antidepressants called SSRIs (Selective Serotonin-Reuptake Inhibitors).

    Now Prozac is being marketed to our dogs under the trade name Reconcile to curb the anxiety from being left alone for long periods of time. The studies used to obtain approval for the drug stated that 30% of animals were found to have 'phobias' or 'fears', while 12% were found to have 'separation-related problems' when parted with their owner. 

    Eli Lilly, the U.S. manufacture, said: 'Treatment for companion animals is a relatively new area for us.' The UK recently approved Prozac for use in pets. Side effects of Reconcile include lethargy, reduced appetite, vomiting, shaking, diarrhea, restlessness, excessive barking, aggression and seizures. 

    top of page

    Kelly - Prozac Withdrawal Success Story

    “ For me this withdrawal program was an obsession…I followed it closely. It worked a miracle in my life! This program is the best out there it covers everything. I am FREE of Prozac and I got my TESTIMONY back! Thank you from the bottom of my heart!

    —Kelly (Prozac Withdrawal Success Story) 




    Abnormal dreams, abnormal ejaculation, abnormal vision, anxiety, diminished sex drive, dizziness, dry mouth, flu-like symptoms, flushing, gas, headache, impotence, insomnia, itching, loss of appetite, nausea, nervousness, rash, sinusitis, sleepiness, sore throat, sweating, tremors, upset stomach, vomiting, weakness, yawning, abnormal taste, agitation, bleeding problems, chills, confusion, ear pain, emotional instability, fever, frequent urination, high blood pressure, increased appetite, loss of memory, palpitations, ringing in the ears, sleep disorders, weight gain


    Severe: visual impairment, tardive dyskinesia, suicidal ideation, arrhythmia exacerbation, heart failure, myocardial infarction, proteinuria, seizures, peptic ulcer, hematemesis, GI bleeding, pancreatitis, cholecystitis, esophageal ulceration, GI obstruction, muscle paralysis, pulmonary hypertension, thrombosis, ventricular fibrillation, coronary vasospasm, stroke, atrial fibrillation, cardiac arrest, bradycardia, pneumothorax, apnea, pulmonary edema, laryngeal edema, ocular hypertension, hearing loss, oliguria, diabetic ketoacidosis, hyperkalemia, torticollis, thrombotic thrombocytopenic purpura (TTP, aplastic anemia, hemolytic anemia, SIADH, torsade de pointes, ventricular tachycardia, erythema nodosum, pulmonary fibrosis, lupus-like symptoms, bronchospasm, erythema multiforme, exfoliative dermatitis, Stevens-Johnson syndrome, anaphylactoid reactions, angioedema, serum sickness, vasculitis,Drug Reaction with Eosinophilia and  Systemic Symptoms (DRESS), laryngospasm, toxic epidermal necrolysis, eosinophilic pneumonia, pulmonary embolism, optic neuritis, hepatic failure, hepatic necrosis, renal failure (unspecified), bone fractures, serotonin syndrome, persistent pulmonary hypertension of the newborn, neonatal abstinence syndrome 

    Moderate: impotence (erectile dysfunction), ejaculation dysfunction, constipation, oral ulceration, melena, esophagitis, cholelithiasis, dysphagia, glossitis, gastritis, colitis, stomatitis, neuropathic pain, myoclonia, teeth grinding (bruxism), migraine, akathisia, ataxia, hypertonia, hostility, psychosis, euphoria, depression, anemia, hypotension, angina, orthostatic hypotension, peripheral edema, edema, vaginal bleeding, atopic dermatitis, skin ulcer, photophobia, conjunctivitis, elevated hepatic enzymes, urinary incontinence, dysuria, hematuria, urinary retention, cystitis, hypothyroidism, hypercholesterolemia, dehydration, hypokalemia, hyperlipidemia, gout, bone pain, synovitis, mania, abdominal pain, fecal incontinence, neuritis, hallucinations, EEG changes, dysarthria, hyperesthesia, dystonic reaction, lymphocytosis, thrombocytopenia, leukopenia, phlebitis, priapism, psoriasis, furunculosis, hypoxia, hypoventilation, hemoptysis, blepharitis, iritis, exophthalmos, hyperacusis, hepatitis, flank pain, glycosuria, hyperglycemia, diabetes mellitus, hypocalcemia, hyperuricemia, myopathy, myasthenia, osteoporosis, confusion, amnesia, QT prolongation, hypertension, palpitations, chest pain (unspecified), dyskinesia, memory impairment, impulse control symptoms, hematoma, bleeding, platelet dysfunction, hyponatremia, galactorrhea, hyperprolactinemia, dyspnea, cataracts, jaundice, hypoglycemia, osteopenia, withdrawal, growth inhibition 

    Mild: insomnia, nausea, headache, asthenia, diarrhea, anorexia, drowsiness, anxiety, tremor, xerostomia, yawning, libido decrease, dyspepsia, pharyngitis, dizziness, hyperhidrosis, urticaria, rash, sinusitis, abnormal dreams, flushing, flatulence, vomiting, pruritus, weight loss, epistaxis, fever, hypersalivation, polydipsia, eructation, paranoia, vertigo, hypoesthesia, ecchymosis, syncope, breast enlargement, orgasm dysfunction, mastalgia, menorrhagia, libido increase, breast discharge, amenorrhea, leukorrhea, photosensitivity, alopecia, maculopapular rash, skin discoloration, acne vulgaris, malaise, hyperventilation, hiccups, mydriasis, xerophthalmia, polyuria, urinary urgency, nocturia, pelvic pain, arthralgia, muscle cramps, paresthesias, hyporeflexia, petechiae, purpura, pallor, hirsutism, seborrhea, parosmia, diplopia, appetite stimulation, weight gain, dysgeusia, emotional lability, hyperkinesis, agitation, hypothermia, chills, otalgia, tinnitus, increased urinary frequency, gynecomastia, influenza 


    Children, growth inhibition, suicidal ideation   

    Fluoxetine is approved for the treatment of depression in children 8 years of age and older, and for the treatment of obsessive-compulsive disorder (OCD) in children 7 years of age and older. The safety and effectiveness of fluoxetine in younger children have not been established. In October 2004, the FDA directed manufacturers of all antidepressants to include a boxed warning detailing the risk of suicide in pediatric patients. A causal role has been established for antidepressants in inducing suicidality in pediatric patients. The risk of suicidality for these drugs was identified in a pooled analysis of 24 placebo-controlled trials (n=4400) lasting up to 16 weeks in pediatric patients with major depressive disorder (MDD), obsessive compulsive disorder (OCD), or other psychiatric disorders. The analysis showed a greater risk of suicidality during the first few months of treatment in those receiving antidepressants (SSRIs and others). The average risk of such events on drug was 4% and 2% for placebo; however, no suicides occurred in these trials. Pooled analysis of short-term clinical trials during early phase treatment with SSRIs and other antidepressants in young adults (18 to 24 years) also showed an increased risk of suicidal thinking and behavior. The clinical need for an antidepressant in children or young adults for any use must be weighed against the risk of increased suicidality; patients who are started on therapy should be observed closely for clinical worsening, suicidality, or unusual changes in behavior, particularly within the first few months of starting therapy or at the time of dose increase or decrease. It is unknown if the suicidality risk in children and young adults extends to longer-term therapy (i.e., beyond several months). The possibility of a suicide attempt is inherent in patients with depressive symptoms, whether these occur in primary depression or in association with another primary disorder. All patients with a history of suicidal ideation or behaviors and those with a prominence of suicidal ideation prior to treatment are considered at an increased risk for suicidal ideation or attempts, and should be closely monitored during treatment with fluoxetine. In patients who exhibit changes in symptoms, worsening of depression or emergent suicidality, a decision should be made to change or discontinue treatment. If discontinuing, medication should be tapered as rapidly as possible, but with recognition that abrupt discontinuation can also cause adverse symptoms. All antidepressants should be prescribed in the smallest quantity consistent with good patient management in order to reduce the risk of overdose. The potential for growth inhibition in pediatric patients should be monitored during SSRI therapy. Monitor height and weight periodically while the patient is receiving fluoxetine. Data are inadequate to determine whether the chronic use of SSRIs causes long-term growth inhibition; however, decreased weight gain has been observed in children and adolescents receiving fluoxetine.  



    top of page




    Discontinuation According to the FDA: 

    Treatment Patients should be advised to take PROZAC exactly as prescribed, and to continue taking PROZAC as prescribed even after their symptoms improve. 

    Patients should be advised that they should not alter their dosing regimen, or stop taking PROZAC without consulting their physician [see Warnings and Precautions (5.15)]. Patients should be advised to consult with their healthcare provider if their symptoms do not improve with PROZAC. 

    If the decision has been made to discontinue treatment, medication should be tapered, as rapidly as is feasible, but with recognition that abrupt discontinuation can be associated with certain symptoms [see Warnings and Precautions


    *While great care has been taken in organizing and presenting the material throughout this website, please note that it is provided for informational purposes only and should not be taken as Medical Advice. 

    *The statements/info on this website have not been evaluated by the Food and Drug Administration (FDA). The products and labels mentioned / sold are not intended to diagnose, treat, cure, or prevent any disease or illness. 

    *The program outlined in Point of Return is not meant to substitute your doctor, instead it is to be utilized with Your physician to help you with your drug withdrawal process and with his or her consent throughout. 

    *This program is not meant to cure or prevent any disease or illness. 

    *Because prescription medications can cause severe withdrawal reactions, do not stop taking any medication without first consulting your physician. The decision to taper any medication should be discussed with your doctor and done with their consent and support throughout the process. More..